HeartBeam Inc. (NASDAQ: BEAT) was recently recognized in a January industry roundup published by Modern Healthcare, which highlighted select medical device companies that achieved meaningful regulatory milestones or demonstrated forward momentum. The article, authored by Lauren Dubinsky, examined recent U.S. Food and Drug Administration (FDA) clearances and approvals across the sector, and HeartBeam was included for advancing its novel HeartBeam System.
The HeartBeam System is a cable-free, high-fidelity ECG platform designed to capture the heart's electrical signals from three distinct directions and synthesize them into a 12-lead ECG for arrhythmia assessment. This technology aims to improve access to clinical-grade data outside of traditional healthcare settings, potentially transforming cardiac care by providing powerful insights wherever the patient is. The recognition underscores HeartBeam's progress as it continues to develop a platform that could redefine cardiac health management.
HeartBeam holds 13 U.S. and 4 international-issued patents related to its technology enablement. The company is focused on creating portable devices that can deliver actionable heart intelligence, allowing physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility. This approach aligns with broader industry trends toward remote monitoring and decentralized healthcare.
The full article can be viewed at https://nnw.fm/1nd5y. For more information about HeartBeam, visit www.HeartBeam.com.
